Guidelines for elderly patients with multimorbidity: how to cope with a dark night without fear.

dianagosalvez Diana Gosálvez Prados última modificación 19/12/2013 10:25

The epidemiological transition has produced a society with a growing number of the elderly affected by multiple chronic diseases which often requires polypharmacy. Despite being the main users of medications, the elderly are largely underrepresented in clinical trials, especially if they have multimorbidity.

Marengoni A.Guidelines for elderly patients with multimorbidity: how to cope with a dark night without fear. Aging Clin Exp Res. 2013 Dec;25(6):703-5. Available at: http://link.springer.com/article/10.1007%2Fs40520-013-0072-3


Artículo

19/12/2013
None

Marengoni A.

Resto de la Unión Europea